Hutchmed stock
Web6 apr. 2024 · HUTCHMED (China) Ltd ( HCM) is near the top in its industry group according to InvestorsObserver. HCM gets an overall rating of 72. That means it scores higher than 72 percent of stocks. HUTCHMED (China) Ltd gets a 96 rank in the Drug Manufacturers - Specialty & Generic industry. WebFor further discussion of these and other risks, see HUTCHMED's filings with the U.S. Securities and Exchange Commission, on AІM and with The Stock Exchange of Hong Kong Limited. HUTCHMED undertakes no obligation to update or revise the information contained in this announcement, whether as a result of new information, future events or ...
Hutchmed stock
Did you know?
WebHUTCHMED (China) Limited (LON:HCM – Get Rating) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 226.08 ($2.76) and traded as low as G 03-14 23:34 Hutchmed Completes Colorectal Cancer Drug Licensing Deal With Takeda Pharmaceutical Web11 apr. 2024 · HUTCHMED (China) Ltd (ADR) is up 5.87% from its previous closing price of $14.64. During the last market session, HUTCHMED (China) Ltd (ADR)’s stock traded …
Web12 apr. 2024 · HUTCHMED (China) Limited anunció que se presentarán datos clínicos y no clínicos nuevos y actualizados relacionados con cinco candidatos a fármacos en investigación de HUTCHMED durante la Reunión Anual 2024 de la Asociación Americana para la Investigación del Cáncer (AACR 2024), que tendrá lugar del 14 al 19 de abril de … Web4 apr. 2024 · Hutchmed (China) Limited 04 April 2024 Press Release HUTCHMED Initiates Registration Phase Enrollments of HMPL-453 for IHCC and... 11/04/2024 14:09:46 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Monitor; Quote; ... Aquis Stock Exchange: Ordinary Share: KYG4672N1198 Price Change % Change Share Price Bid …
Web12 apr. 2024 · 3 Wall Street analysts have issued 12-month price targets for HUTCHMED's stock. Their HCM share price forecasts range from $16.00 to $16.00. On average, they … Web10 apr. 2024 · HUTCHMED (HCM Quick Quote HCM - Free Report) closed the last trading session at $14.65, gaining 3.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term ...
Web12 apr. 2024 · HUTCHMED (Nasdaq/AIM:HCM;HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global …
Web2 dagen geleden · HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted... fisher tradesman yellow cap-o-matic space penWeb12 apr. 2024 · HCM Stock Overview HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and … fisher track in snowWeb2 dagen geleden · HUTCHMED (China) Limited (HCM) Stock Price, Quote & News - Stock Analysis HUTCHMED (China) Limited ( HCM) Add to Watchlist 14.65 +1.80 (14.01%) … can an mri tell if a tumor is benignWeb11 apr. 2024 · HUTCHMED Limited a annoncé que le Dr Karen Jean Ferrante a informé la Société qu'elle se retirerait du Conseil d'administration lors de la prochaine assemblée générale annuelle de la ... can an msp also be an mpWeb2 dagen geleden · -- Hutchmed will present data related to five of its investigational drug candidates at a cancer research forum in Florida from Friday through Wednesday next week. The company will present data... April 12, 2024 can an nba team go 82-0Web4 mrt. 2024 · HCM Stock Overview HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. About the company Rewards Trading at 64.3% below our estimate of its fair value Revenue is forecast to grow 20.78% per year Risk … can an msp have a second jobWeb11 apr. 2024 · HUTCHMED (China) Limited heeft aangekondigd dat Dr. Karen Jean Ferrante de Onderneming heeft meegedeeld dat zij zich bij de komende jaarlijkse algemene vergadering van de Onderneming op 12 mei 2024 zal terugtrekken uit de Raad en dat zij zich niet herkiesbaar zal stellen op de jaarlijkse algemene vergadering zodat zij meer tijd … can an msb be exempt from ctr reporting